Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06602492Phase 1Completed
Phase 1, randomised, open-label trial (2 arms), sponsored by Rochester Institute of Technology. Primary endpoint: Change in Total Particulate Matter (TPM) exposure at 17 days. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06602492.